STOCK TITAN

Nurix Therapeutics: Perceptive reports 4.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

For Nurix Therapeutics, Inc. (NRIX), Perceptive Advisors LLC, Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd. each report beneficial ownership of 5,371,629 common shares, or 4.9% of the class. The Master Fund directly holds the shares; Perceptive Advisors, its investment manager, and Joseph Edelman, its managing member, may each be deemed beneficial owners. Each reports shared voting and dispositive power over the shares and zero sole voting or dispositive power. The reported percentages are based on 109,249,814 shares outstanding as of September 30, 2026.

Beneficial ownership 5,371,629 shares Amount reported by each of the three reporting persons; the Master Fund directly holds the shares.
Percent of class 4.9% Reported by each reporting person.
Shares outstanding 109,249,814 shares Nurix common shares outstanding as of September 30, 2026; used as the basis for the reported ownership percentages.
beneficially owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power 5,371,629.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 5,371,629.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRIX shares do the reporting persons beneficially own?

Each of the three reporting persons reports beneficial ownership of 5,371,629 shares, equal to 4.9% of Nurix's common stock. The reported amounts represent the same shares, not separate holdings to be added together.

Who directly holds the reported NRIX shares?

Perceptive Life Sciences Master Fund, Ltd. directly holds the 5,371,629 shares. Perceptive Advisors LLC and Joseph Edelman do not directly hold shares, but may be deemed beneficial owners through the investment manager and managing member relationships described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





67080M103

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading